Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Effect of haemodiafiltration vs conventional haemodialysis on growth and cardiovascular outcomes in children - the HDF, heart and height (3H) study

R. Shroff, A. Bayazit, CJ. Stefanidis, V. Askiti, K. Azukaitis, N. Canpolat, A. Agbas, A. Anarat, B. Aoun, S. Bakkaloglu, D. Bhowruth, D. Borzych-Dużałka, IK. Bulut, R. Büscher, C. Dempster, A. Duzova, S. Habbig, W. Hayes, S. Hegde, S. Krid, C....

. 2018 ; 19 (1) : 199. [pub] 20180810

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu klinické zkoušky, srovnávací studie, časopisecké články, multicentrická studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19035081

BACKGROUND: Cardiovascular disease is prevalent in children on dialysis and accounts for almost 30% of all deaths. Randomised trials in adults suggest that haemodiafiltration (HDF) with high convection volumes is associated with reduced cardiovascular mortality compared to high-flux haemodialysis (HD); however paediatric data are scarce. We designed the haemodiafiltration, heart and height (3H) study to test the hypothesis that children on HDF have an improved cardiovascular risk profile, growth and nutritional status and quality of life, compared to those on conventional HD. We performed a non-randomised parallel-arm intervention study within the International Paediatric Haemodialysis Network Registry comparing children on HDF and conventional HD to determine annualised change in cardiovascular end-points and growth. Here we present the 3H study design and baseline characteristics of the study population. METHODS: 190 children were screened and 177 (106 on HD and 71 on HDF) recruited from 28 centres in 10 countries. There was no difference in age, underlying diagnosis, comorbidities, previous dialysis therapy, dialysis vintage, residual renal function, type of vascular access or blood flow between HD and HDF groups. High flux dialysers were used in 63% of HD patients and ultra-pure water was available in 52%. HDF patients achieved a median convection volume of 13.3 L/m2; this was associated with the blood flow rate only ((p = 0.0004, r = 0.42) and independent of access type (p = 0.38). DISCUSSION: This is the largest study on dialysis outcomes in children that involves deep phenotyping across a wide range of cardiovascular, anthropometric, nutritional and health-related quality of life measures, to test the hypothesis that HDF leads to improved cardiovascular and growth outcomes compared to conventional HD. TRIAL REGISTRATION: ClinicalTrials.gov: NCT02063776 . The trial was prospectively registered on the 14 Feb 2014.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19035081
003      
CZ-PrNML
005      
20191010121517.0
007      
ta
008      
191007s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12882-018-0998-y $2 doi
035    __
$a (PubMed)30097064
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Shroff, Rukshana $u Great Ormond Street Hospital for Children NHS Foundation Trust, London, WC1N 3JH, UK. Rukshana.Shroff@gosh.nhs.uk.
245    10
$a Effect of haemodiafiltration vs conventional haemodialysis on growth and cardiovascular outcomes in children - the HDF, heart and height (3H) study / $c R. Shroff, A. Bayazit, CJ. Stefanidis, V. Askiti, K. Azukaitis, N. Canpolat, A. Agbas, A. Anarat, B. Aoun, S. Bakkaloglu, D. Bhowruth, D. Borzych-Dużałka, IK. Bulut, R. Büscher, C. Dempster, A. Duzova, S. Habbig, W. Hayes, S. Hegde, S. Krid, C. Licht, M. Litwin, M. Mayes, S. Mir, R. Nemec, L. Obrycki, F. Paglialonga, S. Picca, B. Ranchin, C. Samaille, M. Shenoy, M. Sinha, C. Smith, B. Spasojevic, E. Vidal, K. Vondrák, A. Yilmaz, A. Zaloszyc, M. Fischbach, F. Schaefer, CP. Schmitt,
520    9_
$a BACKGROUND: Cardiovascular disease is prevalent in children on dialysis and accounts for almost 30% of all deaths. Randomised trials in adults suggest that haemodiafiltration (HDF) with high convection volumes is associated with reduced cardiovascular mortality compared to high-flux haemodialysis (HD); however paediatric data are scarce. We designed the haemodiafiltration, heart and height (3H) study to test the hypothesis that children on HDF have an improved cardiovascular risk profile, growth and nutritional status and quality of life, compared to those on conventional HD. We performed a non-randomised parallel-arm intervention study within the International Paediatric Haemodialysis Network Registry comparing children on HDF and conventional HD to determine annualised change in cardiovascular end-points and growth. Here we present the 3H study design and baseline characteristics of the study population. METHODS: 190 children were screened and 177 (106 on HD and 71 on HDF) recruited from 28 centres in 10 countries. There was no difference in age, underlying diagnosis, comorbidities, previous dialysis therapy, dialysis vintage, residual renal function, type of vascular access or blood flow between HD and HDF groups. High flux dialysers were used in 63% of HD patients and ultra-pure water was available in 52%. HDF patients achieved a median convection volume of 13.3 L/m2; this was associated with the blood flow rate only ((p = 0.0004, r = 0.42) and independent of access type (p = 0.38). DISCUSSION: This is the largest study on dialysis outcomes in children that involves deep phenotyping across a wide range of cardiovascular, anthropometric, nutritional and health-related quality of life measures, to test the hypothesis that HDF leads to improved cardiovascular and growth outcomes compared to conventional HD. TRIAL REGISTRATION: ClinicalTrials.gov: NCT02063776 . The trial was prospectively registered on the 14 Feb 2014.
650    _2
$a mladiství $7 D000293
650    _2
$a tělesná výška $x fyziologie $7 D001827
650    _2
$a kardiovaskulární nemoci $x diagnóza $x prevence a kontrola $x psychologie $7 D002318
650    _2
$a dítě $7 D002648
650    _2
$a vývoj dítěte $x fyziologie $7 D002657
650    _2
$a předškolní dítě $7 D002675
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a srdce $x fyziologie $7 D006321
650    _2
$a hemodiafiltrace $x metody $x psychologie $x trendy $7 D017583
650    _2
$a lidé $7 D006801
650    _2
$a chronické selhání ledvin $x diagnóza $x psychologie $x terapie $7 D007676
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a prospektivní studie $7 D011446
650    _2
$a kvalita života $x psychologie $7 D011788
650    _2
$a dialýza ledvin $x metody $x psychologie $x trendy $7 D006435
650    _2
$a výsledek terapie $7 D016896
650    _2
$a mladý dospělý $7 D055815
655    _2
$a klinické zkoušky $7 D016430
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bayazit, Aysun $u Cukurova University, Adana, Turkey.
700    1_
$a Stefanidis, Constantinos J $u A & P Kyriakou Children's Hospital, Athens, Greece.
700    1_
$a Askiti, Varvara $u A & P Kyriakou Children's Hospital, Athens, Greece.
700    1_
$a Azukaitis, Karolis $u Clinic of Paediatrics, Vilnius University, Vilnius, Lithuania.
700    1_
$a Canpolat, Nur $u Cerrahpasa School of Medicine, Istanbul, Turkey.
700    1_
$a Agbas, Ayse $u Cerrahpasa School of Medicine, Istanbul, Turkey.
700    1_
$a Anarat, Ali $u Cukurova University, Adana, Turkey.
700    1_
$a Aoun, Bilal $u Armand Trousseau Hospital, Paris, France.
700    1_
$a Bakkaloglu, Sevcan $u Gazi University Hospital, Ankara, Turkey.
700    1_
$a Bhowruth, Devina $u Great Ormond Street Hospital for Children NHS Foundation Trust, London, WC1N 3JH, UK.
700    1_
$a Borzych-Dużałka, Dagmara $u Medical University of Gdansk, Gdansk, Poland.
700    1_
$a Bulut, Ipek Kaplan $u Ege University Faculty of Medicine, Izmir, Turkey.
700    1_
$a Büscher, Rainer $u University Children Hospital Essen, Essen, Germany.
700    1_
$a Dempster, Claire $u Great Ormond Street Hospital for Children NHS Foundation Trust, London, WC1N 3JH, UK.
700    1_
$a Duzova, Ali $u Hacettepe University, Ankara, Turkey.
700    1_
$a Habbig, Sandra $u University Hospital Cologne, Cologne, Germany.
700    1_
$a Hayes, Wesley $u Great Ormond Street Hospital for Children NHS Foundation Trust, London, WC1N 3JH, UK.
700    1_
$a Hegde, Shivram $u University Hospital of Wales, Cardiff, UK.
700    1_
$a Krid, Saoussen $u Hôpital Necker-Enfants Malades, Paris, France.
700    1_
$a Licht, Christoph $u Hospital for Sick Children, Toronto, Canada.
700    1_
$a Litwin, Mieczyslaw $u Children's Memorial Health Institute, Warsaw, Poland.
700    1_
$a Mayes, Mark $u Great Ormond Street Hospital for Children NHS Foundation Trust, London, WC1N 3JH, UK.
700    1_
$a Mir, Sevgi $u Ege University Faculty of Medicine, Izmir, Turkey.
700    1_
$a Nemec, Rose $u Hospital for Sick Children, Toronto, Canada.
700    1_
$a Obrycki, Lukasz $u Children's Memorial Health Institute, Warsaw, Poland.
700    1_
$a Paglialonga, Fabio $u Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
700    1_
$a Picca, Stefano $u Bambino Gesù' Children Research Hospital, IRCCS, Rome, Italy.
700    1_
$a Ranchin, Bruno $u Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, France.
700    1_
$a Samaille, Charlotte $u Hôpital Jeanne De Flandre, Lille Cedex, France.
700    1_
$a Shenoy, Mohan $u Royal Manchester Children's Hospital, Manchester, UK.
700    1_
$a Sinha, Manish $u Evelina Children's Hospital, London, UK.
700    1_
$a Smith, Colette $u Institute for Global Health, UCL, London, UK.
700    1_
$a Spasojevic, Brankica $u University Children's Hospital, Belgrade, Serbia.
700    1_
$a Vidal, Enrico $u Pediatric Dialysis and Transplant Unit, Padova, Italy.
700    1_
$a Vondrák, Karel $u University Hospital Motol, Prague, Czech Republic.
700    1_
$a Yilmaz, Alev $u Istanbul University Faculty of Medical, Istanbul, Turkey.
700    1_
$a Zaloszyc, Ariane $u Children's Dialysis Center, Strasbourg, France.
700    1_
$a Fischbach, Michel $u Children's Dialysis Center, Strasbourg, France.
700    1_
$a Schaefer, Franz $u Center for Pediatrics and Adolescent Medicine, Heidelberg, Germany.
700    1_
$a Schmitt, Claus Peter $u Center for Pediatrics and Adolescent Medicine, Heidelberg, Germany.
773    0_
$w MED00008194 $t BMC nephrology $x 1471-2369 $g Roč. 19, č. 1 (2018), s. 199
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30097064 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191010121936 $b ABA008
999    __
$a ok $b bmc $g 1451741 $s 1073631
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 19 $c 1 $d 199 $e 20180810 $i 1471-2369 $m BMC nephrology $n BMC Nephrol $x MED00008194
LZP    __
$a Pubmed-20191007

Najít záznam

Citační ukazatele

Možnosti archivace